Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mydecine Innovations Group Inc (OP: MYCOF )

0.0083 -0.0059 (-41.55%)
Streaming Delayed Price Updated: 10:20 AM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mydecine Innovations Group Inc

< Previous 1 2 3 Next >
Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Mydecine Identifies 4 Psychedelic-Related Drugs to Tackle the Mental Health Crisis
Photo by Christopher Ott on 
Via Benzinga
Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program
Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF), a biotech company in the ... 
Via Benzinga
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index. 
Via Talk Markets
Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility
The Nasdaq welcomed its third psychedelics company this week, with 
Via Benzinga
How This Psychedelic Company Could Lead A Turnaround For The Sector
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli... 
Via Benzinga
Mydecine Unveils Four Psychedelic Drug Candidates
Mydecine Innovations Group (OTC:MYCOF), a Denver-based psychedelics research company... 
Via Benzinga
Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July
Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Next Psychedelic Stock To Uplist On The Nasdaq?
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next? 
Via Talk Markets
Mydecine Posts $26.9M Net Loss For 2020: What's Ahead For Psychedelic Stock
Denver-based Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF 
Via Benzinga
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
Entheon Biomedical Corp. announced the 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.